Fecal Occult Blood Tests is the fastest growing segment, North America is the largest market globally
Free Webex Call
The Global In-vitro Colorectal Cancer Screening Tests Market will grow from USD 890.89 Million in 2024 to USD 1.06 billion by 2030 at a 3.10% CAGR. In-vitro colorectal cancer screening tests involve diagnostic procedures utilizing biological samples like stool or blood to detect colorectal cancer or its precursors, thereby enabling early disease identification crucial for improved treatment outcomes. The market's growth is primarily driven by the increasing global prevalence of colorectal cancer and heightened awareness regarding early detection methods. Speak directly to the analyst to clarify any post sales queries you may have.
10% Free customizationThis report comes with 10% free customization, enabling you to add data that meets your specific business needs.
Key Market Drivers
The escalating global incidence of colorectal cancer represents a paramount driver for the in-vitro screening tests market. The increasing number of new cases, particularly among younger individuals, highlights a pressing public health demand for accessible and accurate diagnostic tools. This growing disease burden necessitates expanded screening to enable early detection, which is vital for enhancing patient survival and reducing mortality. According to the American Cancer Society, in January 2024, their annual report, "Cancer Statistics, 2024", indicated that colorectal cancer became the leading cause of cancer death in men and the second in women under 50 years old. This escalating incidence directly stimulates demand for improved in-vitro screening methods.Key Market Challenges
Variable reimbursement policies and the high costs associated with advanced diagnostic technologies present a significant impediment to the expansion of the global in-vitro colorectal cancer screening tests market. These financial barriers restrict patient access to advanced screening options across diverse healthcare systems, particularly when insurance coverage is inconsistent or requires substantial out-of-pocket payments. This directly leads to lower adoption rates, as both healthcare providers and individuals may prioritize more affordable or covered alternatives, even if they are less comprehensive.Key Market Trends
The growing integration of personalized medicine approaches is a significant trend in colorectal cancer screening, enabling tailored strategies based on individual genetic profiles and risk factors. This facilitates targeted early detection through specific biomarkers. According to the American Cancer Society, in January 2024, their "Cancer Statistics, 2024" report indicated nearly 30% of individuals under 50 diagnosed with colorectal cancer attributed their condition to family history or genetic factors, highlighting the need for individualized screening. Guardant Health, Inc.'s November 2025 report in Current Medical Research and Opinion exemplified this, noting its Shield blood-based screening test achieved 95% patient adherence, showcasing improved compliance with precision diagnostics.Key Market Players Profiled:
- Abbott Laboratories, Inc.
- Beckman Coulter, Inc.
- Eiken Chemical Co., Ltd.
- Sysmex Corporation
- Siemens Healthineers AG
- Quest Diagnostics Incorporated
- Merck KGaA
- Kyowa Kirin Co., Ltd.
- Randox Laboratories Ltd.
- R-Biopharm AG
Report Scope:
In this report, the Global In-vitro Colorectal Cancer Screening Tests Market has been segmented into the following categories:By Test Type:
- Fecal Occult Blood Tests
- Biomarker tests
- CRC DNA Screening Tests
By Region:
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global In-vitro Colorectal Cancer Screening Tests Market.Available Customizations:
With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:- Detailed analysis and profiling of additional market players (up to five).
This product will be delivered within 1-3 business days.
Table of Contents
1. Product Overview
2. Research Methodology
3. Executive Summary
5. Global In-vitro Colorectal Cancer Screening Tests Market Outlook
6. North America In-vitro Colorectal Cancer Screening Tests Market Outlook
7. Europe In-vitro Colorectal Cancer Screening Tests Market Outlook
8. Asia Pacific In-vitro Colorectal Cancer Screening Tests Market Outlook
9. Middle East & Africa In-vitro Colorectal Cancer Screening Tests Market Outlook
10. South America In-vitro Colorectal Cancer Screening Tests Market Outlook
11. Market Dynamics
12. Market Trends & Developments
14. Porter's Five Forces Analysis
15. Competitive Landscape
Companies Mentioned
- Abbott Laboratories, Inc.
- Beckman Coulter, Inc.
- Eiken Chemical Co., Ltd.
- Sysmex Corporation
- Siemens Healthineers AG
- Quest Diagnostics Incorporated
- Merck KGaA
- Kyowa Kirin Co., Ltd.
- Randox Laboratories Ltd.
- R-Biopharm AG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 180 |
| Published | November 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 890.89 Million |
| Forecasted Market Value ( USD | $ 1060 Million |
| Compound Annual Growth Rate | 3.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
